The Role of Neprilysin Inhibitors in the Treatment of CV Diseases

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDepartment of Pharmacology and Pharmacotherapyhu_HU
dc.contributor.authorMargalit, Nizan
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.date.accessioned2022-08-18T09:37:47Z
dc.date.available2022-08-18T09:37:47Z
dc.date.created2020-08-27
dc.description.abstract• Neprilysin has an important role in the etiology of some diseases such as cardiovascular diseases. • Neprilysin inhibitors can improve the prognosis of some cardiovascular diseases. • Recent studies found that the combination of neprilysin inhibitors with other drugs such as angiotensin II receptor inhibitor (ARNI) which were used in hypertension, heart failure or diabetes mellitus showed better results than neprilysin inhibitors alone. • Studies on this subject have been greatly developed in recent years, and it is necessary to continue researching this subject to get better results.hu_HU
dc.description.correctorhbk
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent37hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336590
dc.language.isoenhu_HU
dc.subjectNeprilysin Inhibitorshu_HU
dc.subjectTreatment of CV Diseases
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleThe Role of Neprilysin Inhibitors in the Treatment of CV Diseaseshu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)